Get started
Author

Vadim Vitalyevich Tyrenko

Observed names: V Tyrenko, V V Tyrenko, V. Tyrenko, V. V Tyrenko, V. V. Tyrenko, V.V. TYRENKO, V.V. Tyrenko, V.V. Tyrenko Tyrenko, Vadim Tyrenko, Vadim V Tyrenko, Vadim V. Tyrenko, В. В. Тыренко, В.В. Тыренко
Observed institutions: Military Medical Academy, S. M. Kirov Military Medical Academy, Institute of Cytology, Military Medical Academy, Ministry of Defence of the Russian Federation, Military Medical Academy
ORCID: 0000-0002-0470-1109
Observed ORCID: 0000-0002-0470-1109
OpenAlex ID: A5045305601
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 315
PDF
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
2022 · Markus P Schlaich, Marc Bellet, et al. · The Lancet · 249
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 118
PDF
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial
2013 · A. P. Maggioni, S. J. Greene, et al. · European Heart Journal · 56
PDF
Heat shock proteins in cardiosurgery patients
1999 · Oleg N. Demidov, Vadim Vitalyevich Tyrenko, et al. · European Journal of Cardio-Thoracic Surgery · 42
PDF
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40
PDF
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 26
PDF
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 25
PDF
Transplantation of Mesenchymal Stem Cells in Multiple Sclerosis
2012 · M. M. Odinak, G. N. Bisaga, et al. · Neuroscience and Behavioral Physiology · 25
[Transplantation of mesenchymal stem cells in multiple sclerosis].
2011 · M M Odinak, G N Bisaga, et al. · PubMed · 25
Role of renin-angiotensin-aldosterone system in the interaction with coronavirus SARS-CoV-2 and in the development of strategies for prevention and treatment of new coronavirus infection (COVID-19)
2020 · A. Ya. Fisun, D. V. Cherkashin, et al. · Arterial’naya Gipertenziya (Arterial Hypertension) · 19
Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
2020 · V. I. Mazurov, I. Z. Gaydukova, et al. · Rheumatology Science and Practice · 18
PDF
Mechanisms of Damage to the Cardiovascular System in COVID-19
2021 · Alexandr Y. Fisun, Yuriy V. Lobzin, et al. · Annals of the Russian academy of medical sciences · 14
PDF
Modern view on the etiology and immunological aspects of pneumonia
2023 · A. A. Minakov, V. V. Vakhlevskii, et al. · Meditsinskiy sovet = Medical Council · 8
PDF
Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA
2024 · V. I. Mazurov, Sh. F. Erdes, et al. · Modern Rheumatology Journal · 7
PDF
Cardioprotective effect of thiotriazoline in cancer patients
2022 · A. V. Koltsov, V. V. Tyrenko · Russian Journal of Cardiology · 7
PDF
Prognostic Significance of Some Hematological Syndromes in SARS-CoV-2 Infection
2020 · А.С. Поляков, К.В. Козлов, et al. · Гематология Трансфузиология Восточная Европа · 5
Problems of Prevention of Sudden Cardiac Death in Armed Forces of the Russian Federation
2017 · Vadim V Tyrenko, Yu V Ovchinnikov, et al. · Bulletin of the Russian Military Medical Academy · 5
PDF
The role of cytokine system RANKL/RANK/OPG in the regulation of bone metabolism
2014 · D. S Aganov, V. V Tyrenko, et al. · Genes and Cells · 5
PDF
Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders»
2024 · A.I. Martynov, M.M. Tanashyan, et al. · Russian Journal of Preventive Medicine · 4
Prevalence of Heart Failure in a Megalopolis
2022 · A. V. Koltsov, V. V. Tyrenko, et al. · Kardiologiia · 4
PDF
Op0232 Netakimab Reduces the Disease Activity of Radiographic Axial Spondyloarthritis. Results of Astera Study
2019 · Inna Gaydukova, V Mazurov, et al. · Annals of the Rheumatic Diseases · 4
PDF
Assessment of the dynamics of quality of life in patients with chronic heart failure on the background of therapy
2022 · O.T. Kotsoeva, V.V. Tyrenko, et al. · Cardiology News Opinions Training · 3
Possibilities of preclinical diagnosis of anthracycline cardiotoxicity using the technique of "speckle-tracking echocardiography"
2021 · Evgeny V. Kryukov, Oleg Y. Golubtsov, et al. · Bulletin of the Russian Military Medical Academy · 3
PDF
Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19
2020 · S. N. Avdeev, A. V. Bazarova, et al. · Russian Journal of Cardiology · 3
PDF
Works count: 130
Citation count: 1,074
H-index: 13
I10-index: 13
Year
Topic
Type